Williams Kristen Marie's Form 4 filing
Pacira BioSciences, Inc. (PCRX) · filed Mar 23, 2022
- Accession no.
- 0001209191-22-020788
- Filed
- Mar 23, 2022
- Trade date
- Mar 21, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $527.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Williams Kristen MarieCIK 0001296965 | Officer (Chief Administrative Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 21, 2022 | Common Stock | MOption exerciseAcquired | +2,953 | $38.35 | +$113,247.55 | 25,221 | Direct | |
| Mar 21, 2022 | Common Stock | MOption exerciseAcquired | +2,112 | $43.54 | +$91,956.48 | 27,333 | Direct | |
| Mar 21, 2022 | Common Stock | MOption exerciseAcquired | +2,188 | $47.65 | +$104,258.2 | 29,521 | Direct | |
| Mar 21, 2022 | Common Stock | SSaleDisposed | −7,253 | $72.67 | −$527,075.51 | 22,268 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 21, 2022 | Common Stock | MOption exerciseDisposed | −2,953 | $0.00 | $0 | 2,953 | Direct | |
| Mar 21, 2022 | Common Stock | MOption exerciseDisposed | −2,112 | $0.00 | $0 | 10,560 | Direct | |
| Mar 21, 2022 | Common Stock | MOption exerciseDisposed | −2,188 | $0.00 | $0 | 19,685 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.